1. Home
  2. Africa
  3. Southern Africa
  4. Angola

Treating addiction can prevent HIV

Injection - for generic use
Injecting drug use is a major driver of the epidemic (ClintJCL/Flickr)

Alcohol and drug addiction are major drivers of the HIV/AIDS epidemic in many parts of the world, but for political and ideological reasons, scientists and clinicians have tended to shy away from this area of HIV research, while governments and donors have been reluctant to fund programmes targeting addicts.

This was the theme of several presentations on the implications of drug and alcohol dependence in HIV prevention and treatment at the 5th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Cape Town, South Africa, on Tuesday.

An analysis of a number of studies on the association between alcohol use and HIV in sub-Saharan Africa found that drinkers had a 70 percent higher risk of contracting HIV compared to non-drinkers.

"Programmes aimed at reducing alcohol consumption could reduce HIV infections," said Dr Saidi Kapiga of the Harvard School of Public Health, but few such programmes exist. "It's something we're just not talking about, but [alcohol] is a major driver of the epidemic."

Nora Volkow, director of the National Institute on Drug Abuse (NIDA) at the US National Institutes of Health, described addiction as a chronic brain disease mainly determined by genetics and environmental factors, but this had not prevented addicts from being highly stigmatized, and HIV-positive addicts from being doubly stigmatized.

Drug addiction has many serious health consequences, including a greater risk of infectious diseases such as HIV, Volkow said. "You can't cure drug addiction, but you can treat it, and you should ... treatment of drug addiction is a way to prevent HIV."

Read more
 HIV among injecting drug users on the rise
 Too drunk to think - alcohol abuse and HIV
 Dangerous Paradise - sex, drugs and HIV
 Risky sex on drugs a challenge for HIV prevention
 A Cleaner Fix

Behavioural therapy and substitution treatment using methadone or similar drugs to help users overcome their addictions and lower their HIV risk are unavailable in most settings, or form part of pilot programmes that are never scaled up or integrated into public health care systems.

Eastern Europe and Central Asia have experienced an epidemic in drug use since the 1990s, with the result that injecting drug users now make up 85 percent of people living with HIV in some parts of the region.

Konstantin Lezhentsev, of the Harm Reduction Programme run by the Open Society Institute, said a few countries in Eastern Europe had begun offering substitution treatment, but high levels of stigma, repressive drug laws, a lack of guidance on implementation, and a reluctance by medical professionals, government and NGOs to address the problem meant that such programmes rarely got beyond the pilot stage.

In South Africa a colossal increase in mephamphetamine use since 2003 is contributing to the spread of HIV in a country that already has the largest burden in the world. Charles Parry, of the Medical Research Council, said users experience a sense of euphoria, heightened self-confidence and sexuality that can lead them to having multiple sexual partners and sharing needles.

Substitute medications to treat methamphetamine addiction are still in development, but long-term behavioural therapy could be effective. Despite the evidence that "methamphetamine treatment equals HIV prevention", said Parry, "we haven't really progressed beyond research studies; we need to operationalize them by implementing initiatives we know work."


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article
Join the discussion

We uncovered the sex abuse scandal that rocked the WHO, but there’s more to do

We just covered a report that says the World Health Organization failed to prevent and tackle widespread sexual abuse during the Ebola response in Congo.

Our investigation with the Thomson Reuters Foundation triggered this probe, demonstrating the impact our journalism can have. 

But this won’t be the last case of aid worker sex abuse. This also won’t be the last time the aid sector has to ask itself difficult questions about why justice for victims of sexual abuse and exploitation has been sorely lacking. 

We’re already working on our next investigation, but reporting like this takes months, sometimes years, and can’t be done alone. 

The support of our readers and donors helps keep our journalism free and accessible for all. Donations mean we can keep holding power in the aid sector accountable, and do more of this. 

Become a member today and support independent journalism

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.